US pharma major AbbVie yesterday announced a $195 million investment in its North Chicago, Illinois manufacturing plant to ...

UK-based contract research development and manufacturing organization (CRDMO) Arcinova, a subsidiary of Quotient Sciences, ...

With the threat of US tariffs on pharmaceuticals looming in the coming weeks, Morningstar DBRS has taken a closer look at ...

The US Food and Drug Administration approved New Jersey, USA-based Insmed’s (Nasdaq: INSM) fibrosis bronchiectasis (NCFB), a ...

Evotec SE (XETRA: EVT) reported second-quarter 2025 revenues of $188 million, down 6% year-on-year, as strength in its biologics division partly offset weaker demand in discovery and preclinical ...

An Expert View from Lindsay Mateo, chief commercial officer at Weave Bio.

US pharma giant Pfizer and Japan’s Astellas Pharma today announced positive top-line results from the Phase III EV-303 ...

US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...

US pharma major Eli Lilly (NYSE: LLY) is partnering with the UK’s Department for Science, Innovation and Technology to fund ...

UK and USA-listed PureTech Health today announced the launch of a new founded entity to be called Celea Therapeutics.

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

US biotech Rezo Therapeutics today announced the appointment of Derek Hicks as its chief executive (CEO). With more than 25 ...